This Is Your Brain on Drugs

Image: Paul Sale Vern Hoffman/Aurora Photos (background); iStockphoto (head)

In the 1954 foundational text of the Age of Aquarius, The Doors of Perception, Aldous Huxley describes his encounters with mescaline, a psychoactive substance derived from the peyote cactus and traditionally used by Native Americans for religious purposes. Huxley?s experiences include profound changes in the visual world, colors that induce sound, the telescoping of time and space, the loss of the notion of self, and feelings of oneness, peacefulness and bliss more commonly associated with religious visions or an exultant state: ?A moment later a clump of Red Hot Pokers, in full bloom, had exploded into my field of vision. So passionately alive that they seemed to be standing on the very brink of utterance, the flowers strained upwards into the blue.... I looked down at the leaves and discovered a cavernous intricacy of the most delicate green lights and shadows, pulsing with undecipherable mystery.? Yet remarkably these enhanced percepts are not grounded in larger but in reduced brain activity, as a recent experiment reports. More on that in a moment.

Mescaline, together with psilocybin, another natural psychoactive compound produced by ?magic? mushrooms, and lysergic acid diethylamide (LSD or, simply, acid), a potent synthetic psychedelic drug, became widely popular in the 1960s counterculture. The striking similarities between the reports of LSD users and symptoms of acute psychosis led researchers to postulate that serotonin, a chemical-signaling compound or neurotransmitter released by certain groups of neurons in the brain stem, helped to mediate both types of experiences. Indeed, it is now quite certain that the characteristic subjective and behavioral effects of psychedelics are initiated via stimulation of serotonin 2A receptors (known as 5-HT2A) on cortical neurons.

All these hallucinogens were declared controlled drugs in the late 1960s and early 1970s for a variety of medical, political and cultural reasons. Their use moved underground, and research on their psychological, physiological and neuronal effects all but ceased. With the realization of possible therapeutic benefits of psychedelics to reduce anxiety and chronic pain, however, the societal taboos against scientific research on their neurobiology have somewhat relaxed. A number of well-controlled European studies have carefully explored the action of hallucinogens on the brains of normal volunteers [see ?Psychedelic Healing?? by David Jay Brown; Scientific American Mind, December 2007/January 2008].

Functional brain-imaging experiments done at the end of the past century using positron-emission tomography (PET) found marked activation in the frontal lobe of volunteers who had taken hallucinogens, in particular in the prefrontal cortex (PFC), anterior cingulate cortex (ACC) and the insula cortex. This was in line with the expectation that the intensification of ordinary experiences and the consciousness-expanding aspects that are so widely associated with psychedelics would be reflected in higher than usual brain activity. Now comes a study from David Nutt, a psychopharmacologist at Imperial College London, and his colleagues that completely upends this view.

Turn On, Tune In and Drop Out
The British scientists injected either a harmless saltwater concoction (a placebo) or two milligrams of psilocybin directly into the veins of 30 volunteers while they were lying inside a magnetic scanner. As expected, the subjects experienced within a minute or two the effects of the drug. During their short ?trip,? their brains were scanned with one of two different functional MRI techniques. Both gave consistent but very surprising results.

Brain activity was widely reduced! That is, these mind-altering drugs decreased hemodynamic activity, including blood flow, in selected regions, such as the thalamus, the medial prefrontal cortex (mPFC), the ACC and the posterior cingulate cortex (PCC). Activity in these regions dropped by up to 20 percent, relative to before the injection. Even more striking, the deeper the reduction in activity in the ACC and mPFC, the stronger the subject felt the effects of the hallucinogen. Nowhere did activity show an increase. Furthermore, the communication between the PFC and cortical regions in the back of the brain was also disrupted. The surprise is not that reduction of hemodynamic activity in specific sectors of the brain is unheard of. Nor was the activity completely turned off?that would lead within minutes to permanent damage and brain death.

michael pineda charles taylor calvin johnson calvin johnson carl crawford mad cow disease powerball